Biotech
- Updated
- Wall Street
This mysterious company has never sold a single product. Its founder is now worth $51 billion
A company that aims to treat neurological conditions such as ADHD and autism has made a dizzying share price surge without a single sale. It has made its founder very rich.
- Angel Adegbesan and Dylan Sloan
Latest
- Opinion
- IVF
The collateral damage from Monash IVF’s colossal embryo bungles
Monash IVF hasn’t just undermined its own reputation and customer confidence; it must result in a confidence wobble for the entire industry.
- Elizabeth Knight
Hugh once delivered cheese to the Queen. Now he’s built the key to synthetic life
The first-ever synthetic multicellular organism is ready to come to life after a Sydney breakthrough 10 years in the making.
- Angus Dalton
Falling vaccination rates in Trump’s America hit Australian giant
CSL’s profits have taken a hit from Americans’ reluctance to get vaccinated, sending its shares downward.
- David Swan
- Analysis
- Mesoblast Limited
Riding the scariest rollercoaster on the ASX
If you thought crypto investors need to have strong stomachs, spare a thought for the investors who try their luck in the biotech sector.
- William Bennett
It introduced Ozempic to the world. Now it must remake itself
Danish drugmaker Novo Nordisk has eclipsed French luxury group LVMH to become Europe’s most valuable company – thanks to demand for diabetes and weight-loss drugs.
- Eshe Nelson
The artificial heart set to transform medicine – and the Aussie who invented it
Biomedical engineer Daniel Timms lost his father to heart disease, but their kitchen-top tests helped him hone a radical idea.
- Amanda Hooton
- Magazine
- Good Weekend
The April 20 Edition
The Aus-designed artificial heart set to revolutionise medicine | Preppers go mainstream | A sperm donor’s message to his progeny
- Opinion
- Health
Our track record in medical innovation can only be maintained with funding support
Australian researchers are responsible for a series of globally significant medical inventions and innovations.
- The Herald's View
Future of medical research in doubt as question mark lingers over $45 million funding
The future of a government funding program which has assisted teams developing artificial hearts and turning spider venom into drug therapies is in doubt.
- Mary Ward
Original URL: https://www.watoday.com.au/topic/biotechnology-5v0